Real news is usually released pre-market. No?
Stop pumping. You are going to make me dump my shares in the morning.
.....people to buy?
-In September 2011 the FDA issued Kips Bay a non-approvable letter, asking for more information on the eSVS mesh before granting IDE approval for perform pivotal human trials.
-That decision sent KIPS shares plummeting over $2.00 to an new all-time low in a single day.
-"If the FDA approves the amended IDE Application, U.S. physicians will then be allowed to begin enrolling patients," according to the filing. "Kips Bay Medical has already contacted prominent U.S. heart centers that are taking steps to secure internal approvals of their institutional review boards and administration/finance departments to participate in the study."
-THEY JUST GOT APPROVAL TO ENROLL ADDITIONAL PATIENTS BY THE FDA.
- Translation- The product is working.